Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.

Guangzhou Natai Biomedical Technology Co., Ltd., part of Sirnaomics, Inc., is a company headquartered in Guangzhou, China. The firm manufactures biomedical products. It was founded in 2012 by Sheng Gao Tang, Yang Lu and Jian Jun Ji. Sheng Gao Tang has been the CEO since the company founding. Guangzhou Natai Biomedical Technology Co., Ltd. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.

Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a company headquartered in Suzhou, China, that develops nucleic acid drugs. It was founded in 2008 by David Mark Evans and Yang Lu. Yang Lu has been the CEO since the inception date.

Sirnaomics is a clinical-stage biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference (RNAi) technology. The RNAi technology is used to discover and develop novel therapeutics with a focus on oncology, anti-fibrotic therapeutics, and viral infection. Its proprietary Polypeptide Nano-Particle (PNP) technology is used for small interfering RNA (siRNA) drug delivery. This technology allows accessing the tumor micro-environment (TME), as well as various cell types in the liver. Sirnaomics was founded by Patrick Y. Lu and David M. Evans in 2007 and is based in Gaithersburg, Maryland.

Posvax Co. Ltd. is a company headquartered in Gangseo-gu, the South Korea. The firm operates as a biopharmaceutical company that develops prophylactic vaccines and anticancer drugs. It was founded in 2018 by Hong-Jin Kim.

Jiangsu Yahong Meditech Co., Ltd. engages in the research, development, production and commercialization of medicines in the fields of urogenital system tumors and other major diseases fields. It provides patients with integrated solutions for diagnosis and treatment. The company's products include APL-1202, APL-1501, APL-1706, APL-1702, ASN-1764, ASN-1780, APL-1901, APL-1401, and ASN-1733. Jiangsu Yahong Meditech was founded by Ke Pan and Cheng Rui Zhuang on March 16, 2010 and is headquartered in Shanghai, China.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. INOVIO is the first and only company to have clinically demonstrated that DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. Specifically, INOVIO's lead candidate VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, demonstrated it destroyed and cleared high-risk HPV 16 and 18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 90% of anal cancer, and 69% of vulvar cancer.

Part of Merck & Co., Inc., Merck Sharp & Dohme (UK) Ltd. is a British company located in Hoddesdon that functions as an investment holding company. It was founded in 1928.

Chongqing Xutian Biotechnology Co., Ltd., established on 2016-06-03, Business scope includes biotechnology development,transfer,Consulting and Services;Medical device research and development,Production,Sales;Separation and purification of traditional Chinese medicine;Chinese medicine powder,pill,decoction,gel,Coupling agent,ointment,patch,spray,Production, processing and sales of biological preparations;disinfection products,hygiene products,Health products,dairy products,cosmetic,drug development,Production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)*****

Guangdong Hybribio Biotech Co., Ltd. engages in the research, development, production, and sale of nucleic acid molecular diagnostic products in China. It also provides on-site technical training and after-sales technical service support. The company was founded by Qiao Zhong Guan on June 13, 2003 and is headquartered in Chaozhou, China.

Shenzhou Cell Engineering Co Ltd. is a private company headquartered in China. The firm produces monoclonal antibodies, recombinant proteins and vaccines.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Shanghai Jielong Investment Management Co., Ltd., established on 2015-03-11, Business scope includes investment management,Investment Advisory,Business Consulting,Business Management Consulting;international trade,Re-export trade,Trade between enterprises in the region and trade agency in the region;Daily necessities,electronic product,Equipment,Office Supplies,Class I medical device,Metal materials and products(steel,precious metal,Except for rare metals)Wholesale,commission agent(except auction),Import and export and other related supporting business;engaged in biotechnology(remove human stem cells,Development and application of genetic diagnosis and treatment technology),Information Technology,electronic technology,computer,mechanical technology,Energy Technology,Technology development in the field of environmental technology,technical consulting,Technical Services,technology transfer. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Yahong Pharmaceutical Technology Co., Ltd., established on 2017-11-17, Business scope includes general items:Engaged in technology development in the field of medical technology,technical consulting,Technical Services,technology transfer(human stem cells,Except for the development and application of genetic diagnosis and treatment technology);Engaged in the import and export of goods and technology;Intellectual property agency;Business Consulting;Planning of cultural and artistic exchange activities(show manager,Except for commercial performances);Business Management Consulting;Expo Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hangzhou Baiyin Biotechnology Co., Ltd., established on 2018-01-09, Business scope includes technology development,Technical Services,technical consulting,Technology Promotion:Diagnostic reagents(Removal of hazardous chemicals and precursor chemicals),laboratory instrument,Biological reagents and consumables(Removal of hazardous chemicals and precursor chemicals);Production:First,two,Three categories6840In vitro diagnostic reagents;Sales:laboratory apparatus,Laboratory reagents and consumables(Removal of hazardous chemicals and precursor chemicals),First,two,Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Changsha Kaipu Medical Laboratory Co., Ltd., established on 2014-12-02, Business scope includes licensed projects:medical service;Inspection and testing service;Class III medical device business;Class III Medical Device Leasing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Machinery and Equipment Leasing;Class II Medical Device Leasing;General Equipment Repair;electrical equipment repair;Instrument Repair;Special Equipment Repair;Medical Research and Experimental Development;Information Consulting Service(Not including licensing information consulting services);Health Consulting Services(Does not include medical services);Engineering technical service(planning management,survey,design,Except supervision);Engineering Management Services;Research and development of bio-based materials technology;Sales of bio-based materials;Biochemical product technology research and development;Non-residential real estate leases;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class I Medical Device Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

MIKROGEN GmbH is a German private company located in Neuried that manufactures pharmaceutical products. Erwin Soutschek is currently the CEO of the firm.

Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.